OPomD

· Amgen

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OPomD, covering 2024-09-26 to 2024-09-26. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1b Study Evaluating OPomD in Relapsed or Refractory Multiple Myeloma [Phase 1]